Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin therapy vs lifestyle intervention in gestational diabetes mellitus
ChiCTR2500104279Phase 4Completed
- Sponsor
- The Fourth Hospital of Shijiazhuang
- Start
- Jun 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of human insulin in gestational diabetes mellitus (GDM) (2 arms), sponsored by The Fourth Hospital of Shijiazhuang. Primary endpoints: Blood lipid, Glycated hemoglobin and 3 more. Started Jun 2025; status: completed.
02
Drugs
human insulin
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on ChiCTR2500104279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500104279.